001447061 000__ 04059cam\a2200481\a\4500
001447061 001__ 1447061
001447061 003__ OCoLC
001447061 005__ 20230310004100.0
001447061 006__ m\\\\\o\\d\\\\\\\\
001447061 007__ cr\un\nnnunnun
001447061 008__ 220528s2022\\\\sz\\\\\\o\\\\\000\0\eng\d
001447061 019__ $$a1321785477
001447061 020__ $$a3030930238$$q(electronnic bk.)
001447061 020__ $$a9783030930233$$q(electronic bk.)
001447061 020__ $$z9783030930226
001447061 020__ $$z303093022X
001447061 0247_ $$a10.1007/978-3-030-93023-3$$2doi
001447061 035__ $$aSP(OCoLC)1321789660
001447061 040__ $$aEBLCP$$beng$$epn$$cEBLCP$$dGW5XE$$dYDX$$dEBLCP$$dOCLCQ$$dN$T$$dUKAHL$$dGWL$$dOCLCQ
001447061 049__ $$aISEA
001447061 050_4 $$aK3611.G46
001447061 08204 $$a344.04/196$$223/eng/20220609
001447061 24500 $$aRegulation of genome editing in human iPS cells :$$ba comparative legal analysis of national regulatory frameworks for IPSC-based cell/gene therapies /$$cHans-Georg Dederer, Gregor Frenken, editors.
001447061 260__ $$aCham, Switzerland :$$bSpringer,$$c2022.
001447061 300__ $$a1 online resource (340 pages)
001447061 336__ $$atext$$btxt$$2rdacontent
001447061 337__ $$acomputer$$bc$$2rdamedia
001447061 338__ $$aonline resource$$bcr$$2rdacarrier
001447061 5050_ $$aIntroduction -- Biological aspects of genome editing in iPS cells -- Ethical aspects in the context of genome editing -- Regulation of genome editing in iPS cells : Germany -- Regulation of genome editing in iPS cells : France -- Regulation of genome editing in iPS cells : Switzerland -- Regulation of genome editing in iPS cells : United States -- Regulation of genome editing in iPS cells : Japan -- Regulation of genome editing in iPS Cells : Republic of Korea -- Comparative analysis.
001447061 506__ $$aAccess limited to authorized users.
001447061 520__ $$aThe book provides a concise overview of currently applicable regulatory frameworks of states which are among the world leaders in research and development (R & D) of cell and gene therapies. Developments in genome editing are expected to lead to new possibilities for the treatment of hereditary diseases in humans. The treatment of such often severe but hitherto uncurable diseases can be based on genome-edited induced pluripotent stem cells (iPS cells). Such treatments constitute combined cell/gene therapies. These therapies need to be governed by a regulatory framework which ensures quality, safety, and efficacy of the relevant therapeutic products. On the other hand, such regulations may retard product approval and impede R & D. Accordingly, national regulations for therapies based on genome-edited iPS cells are an important and, as the case may be, decisive factor for both researchers and industry regarding their decision where to locate their R & D activities. Therefore, regulatory frameworks impact significantly on the competitiveness of states and their economies. This is why a comparative analysis of laws and regulations of different countries matters. Such a comparative legal analysis provides an important insight into regulatory concepts which, in turn, may inspire adjustments of, or amendments to, domestic legal regimes. For this purpose, experts present country reports on France, Germany, Japan, South Korea, Switzerland, and the USA. The reports on France and Germany also refer to the parameters and implications arising from pertinent EU law. This contributed volume is aimed at researchers, but also at, e.g., legal scholars, lawmakers, regulators, and political decision makers.
001447061 588__ $$aOnline resource; title from PDF title page (SpringerLink, viewed June 9, 2022).
001447061 650_0 $$aGene editing$$xLaw and legislation.
001447061 655_0 $$aElectronic books.
001447061 7001_ $$aDederer, Hans-Georg.
001447061 7001_ $$aFrenken, Gregor.
001447061 77608 $$iPrint version:$$aDederer, Hans-Georg.$$tRegulation of Genome Editing in Human IPS Cells.$$dCham : Springer International Publishing AG, ©2022$$z9783030930226
001447061 852__ $$bebk
001447061 85640 $$3Springer Nature$$uhttps://univsouthin.idm.oclc.org/login?url=https://link.springer.com/10.1007/978-3-030-93023-3$$zOnline Access$$91397441.1
001447061 909CO $$ooai:library.usi.edu:1447061$$pGLOBAL_SET
001447061 980__ $$aBIB
001447061 980__ $$aEBOOK
001447061 982__ $$aEbook
001447061 983__ $$aOnline
001447061 994__ $$a92$$bISE